{"docid":"VWS-WOO-08-1069285","collapsed":true,"count":1,"unchecked":1,"snapshots_total":7,"versions":[{"archive_id":"folder_import_33523_bfc981051513b0e4d75cea7b39ce51e0","bestandsnaam":"VWS-WOO-08-1069285.pdf","created_date":"2025-09-07 17:22:44","last_seen":"2025-09-07 17:22:44","from_file":"folder_import","bron":"/volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-1069285.pdf","snippet":"1069285\nTo: 842s ERED@minvws.ni);IXETN IEXETN @minvws.n]From: 5.1.2e\nSent:Fri1/29/2021 6:17:39 PM\nSubject: FW: EUCOVID-19 Vaccine AstraZeneca recommended foruse intheEU\nReceived:Fri1/29/2021 6:17:40 P","digest":"b3780daf2304","dupes":6,"date_to":"2025-09-07 17:22:44","date_from":"2025-02-18 12:18:04","unchecked":false},{"archive_id":"d056eb8f-c1a8-404c-bd70-65258c778303","bestandsnaam":"VWS-WOO-08-1069285.pdf","created_date":"2026-10-29 07:44:19.040593+01","last_seen":null,"from_file":"folder_import","bron":"W:\\openrijksoverheid\\documenten_files\\VWS-WOO-08-1069285.pdf","snippet":"","digest":null,"dupes":1,"unchecked":true,"date_to":"2026-10-29 07:44:19.040593+01","date_from":"2026-10-29 07:44:19.040593+01"}],"raw":[{"archive_id":"d056eb8f-c1a8-404c-bd70-65258c778303","bestandsnaam":"VWS-WOO-08-1069285.pdf","created_date":"2026-10-29 07:44:19.040593+01","last_seen":null,"from_file":"folder_import","bron":"W:\\openrijksoverheid\\documenten_files\\VWS-WOO-08-1069285.pdf","snippet":"","digest":null},{"archive_id":"folder_import_33523_bfc981051513b0e4d75cea7b39ce51e0","bestandsnaam":"VWS-WOO-08-1069285.pdf","created_date":"2025-09-07 17:22:44","last_seen":"2025-09-07 17:22:44","from_file":"folder_import","bron":"/volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-1069285.pdf","snippet":"1069285\nTo: 842s ERED@minvws.ni);IXETN IEXETN @minvws.n]From: 5.1.2e\nSent:Fri1/29/2021 6:17:39 PM\nSubject: FW: EUCOVID-19 Vaccine AstraZeneca recommended foruse intheEU\nReceived:Fri1/29/2021 6:17:40 P","digest":"b3780daf2304"},{"archive_id":"VWS-WOO-3477674-1040721-pdo-1f026c98-b466-6708-a84b-65673e0af118.zip_3460","bestandsnaam":"VWS-WOO-08-1069285.pdf","created_date":"2025-09-04 17:03:04","last_seen":"2025-09-04 17:03:04","from_file":"VWS-WOO-3477674-1040721-pdo-1f026c98-b466-6708-a84b-65673e0af118.zip","bron":"../../archieven_files/VWS-WOO-3477674-1040721-pdo-1f026c98-b466-6708-a84b-65673e0af118.zip","snippet":"1069285\nTo: 842s ERED@minvws.ni);IXETN IEXETN @minvws.n]From: 5.1.2e\nSent:Fri1/29/2021 6:17:39 PM\nSubject: FW: EUCOVID-19 Vaccine AstraZeneca recommended foruse intheEU\nReceived:Fri1/29/2021 6:17:40 P","digest":"b3780daf2304"},{"archive_id":"331542","bestandsnaam":"VWS-WOO-08-1069285-FW_EU_COVID-19_Vaccine_AstraZeneca_recommended_for_use_in_the_EU.pdf","created_date":"2025-03-18 09:30:25","last_seen":"2025-03-18 09:30:25","from_file":"2024.075-VWS-WOO-3477674-1040721-pdo.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\2024.075-VWS-WOO-3477674-1040721-pdo.zip","snippet":"1069285\nTo: 842s ERED@minvws.ni);IXETN IEXETN @minvws.n]From: 5.1.2e\nSent:Fri1/29/2021 6:17:39 PM\nSubject: FW: EUCOVID-19 Vaccine AstraZeneca recommended foruse intheEU\nReceived:Fri1/29/2021 6:17:40 P","digest":"b3780daf2304"},{"archive_id":"244630","bestandsnaam":"VWS-WOO-08-1069285-FW_EU_COVID-19_Vaccine_AstraZeneca_recommended_for_use_in_the_EU.pdf","created_date":"2025-02-27 09:25:05","last_seen":"2025-02-27 09:25:05","from_file":"2023.057-VWS-WOO-3477674-1040721-pdo.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\2023.057-VWS-WOO-3477674-1040721-pdo.zip","snippet":"1069285\nTo: 842s ERED@minvws.ni);IXETN IEXETN @minvws.n]From: 5.1.2e\nSent:Fri1/29/2021 6:17:39 PM\nSubject: FW: EUCOVID-19 Vaccine AstraZeneca recommended foruse intheEU\nReceived:Fri1/29/2021 6:17:40 P","digest":"b3780daf2304"},{"archive_id":"114254","bestandsnaam":"VWS-WOO-08-1069285-FW_EU_COVID-19_Vaccine_AstraZeneca_recommended_for_use_in_the_EU.pdf","created_date":"2025-02-18 12:18:13","last_seen":"2025-02-18 12:18:13","from_file":"Besluit__dossier_nr_-7b96e539f6d667469c9ac30d7d6532aa0289bb878a63cc17383edcca0c24d48d.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\Besluit__dossier_nr_-7b96e539f6d667469c9ac30d7d6532aa0289bb878a63cc17383edcca0c24d48d.zip","snippet":"1069285\nTo: 842s ERED@minvws.ni);IXETN IEXETN @minvws.n]From: 5.1.2e\nSent:Fri1/29/2021 6:17:39 PM\nSubject: FW: EUCOVID-19 Vaccine AstraZeneca recommended foruse intheEU\nReceived:Fri1/29/2021 6:17:40 P","digest":"b3780daf2304"},{"archive_id":"67921","bestandsnaam":"VWS-WOO-08-1069285-FW_EU_COVID-19_Vaccine_AstraZeneca_recommended_for_use_in_the_EU.pdf","created_date":"2025-02-18 12:18:04","last_seen":"2025-02-18 12:18:04","from_file":"Besluit__dossier_nr_-56dedcf3b5a6fd477519d5eceba72bb3d95085d3ef569f0f6cb8c5110cd5ac60.zip","bron":"Z:\\ARCHIEF WOO Documenten\\archieven_files\\Besluit__dossier_nr_-56dedcf3b5a6fd477519d5eceba72bb3d95085d3ef569f0f6cb8c5110cd5ac60.zip","snippet":"1069285\nTo: 842s ERED@minvws.ni);IXETN IEXETN @minvws.n]From: 5.1.2e\nSent:Fri1/29/2021 6:17:39 PM\nSubject: FW: EUCOVID-19 Vaccine AstraZeneca recommended foruse intheEU\nReceived:Fri1/29/2021 6:17:40 P","digest":"b3780daf2304"}],"filename":"FW: EU COVID-19 Vaccine AstraZeneca recommended for use in the EU","truncated":false,"elapsed_ms":15}